GORE DUALMESH BIOMATERIAL
Report
- Report Number
- 3003910212-2011-00015
- Event Type
- Injury
- Date Received
- August 5, 2011
- Date of Event
- February 22, 2011
- Report Date
- August 4, 2011
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- FTL
- PMA / PMN Number
- K992189
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- PHYSICIAN
Narratives
METHOD: THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNAVAILABLE, THEREFORE, A DIRECT PRODUCT ANALYSIS AND REVIEW OF MANUFACTURING RECORDS WAS NOT CONDUCTED. THE POTENTIAL FOR SUCH EVENTS IS ADDRESSED IN THE DEVICE'S INSTRUCTIONS-FOR-USE WHICH STATES, "POSSIBLE ADVERSE REACTIONS WITH THE USE OF ANY TISSUE DEFICIENCY PROSTHESIS MAY INCLUDE, BUT ARE NOT LIMITED TO, CONTAMINATION, INFECTION, INFLAMMATION, ADHESION, FISTULA FORMATION, SEROMA FORMATION, HEMATOMA AND RECURRENCE." ALL INFO HAS BEEN MADE AVAILABLE FOR TRACKING AND TRENDING.
IT WAS REPORTED TO GORE THAT A PT UNDERWENT AN EXPLORATORY LAPAROTOMY FOR PERSISTENT HIGH GRADE BOWEL OBSTRUCTION. LYSIS OF ADHESIONS AND A SMALL BOWEL RESECTION WAS PERFORMED AFTER ENTERING THE ABDOMEN THROUGH WELL INCORPORATED GORE DUALMESH BIOMATERIAL. GORE DUALMESH BIOMATERIAL HAD BEEN IMPLANTED EIGHT YEARS PRIOR FOR VENTRAL HERNIA REPAIR. NINE DAYS POST OPERATIVE; THE PT PRESENTED IN SEPTIC SHOCK. THERE WAS FECULENT WOUND DRAINAGE AND CT REVEALED EXPOSED GORE DUALMESH BIOMATERIAL AT THE BASE OF THE MIDLINE INCISION. THE PT WAS RESUSCITATED AND A WOUND VAC WAS APPLIED. SEVERAL DAYS LATER, THE MESH WAS REMOVED AND THE FASCIA WAS REAPPROXIMATED ALONG THE MIDLINE AND AN ONLAY REPAIR WAS PERFORMED. IT WAS REPORTED THAT THE PT'S RECOVERY WAS UNREMARKABLE AND THE INCISION HEALED WITHOUT COMPLICATION ONE MONTH AFTER SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE DUALMESH BIOMATERIAL | FTL / MESH, SURGICAL, POLYMERIC | FTL | W.L. GORE & ASSOCIATES | WLG101 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Required Intervention |